Hemophagocytic Syndrome Red Cell Aplasia

**No.** Hemophagocytic syndrome (hemophagocytic lymphohistiocytosis, HLH) and pure red cell aplasia (PRCA) are distinct clinicopathologic entities with fundamentally different bone marrow findings and lineage involvement, and HLH does not present with isolated PRCA. --- ## Differential Diagnosis: HLH vs. PRCA ### Hemophagocytic Lymphohistiocytosis (HLH) **Definition & Pathophysiology** HLH is a life-threatening syndrome of excessive immune activation characterized by uncontrolled proliferation of macrophages and cytotoxic T lymphocytes, leading to a hyperinflammatory state [1][3]. The pathophysiology involves defective downregulation of activated macrophages by NK cells and cytotoxic T cells, resulting in a cytokine storm [3]. **Diagnostic Criteria (HLH-2004)** Diagnosis requires either: - A molecular diagnosis consistent with HLH (e.g., *PRF1*, *UNC13D*, *STX11*, *STXBP2* mutations), **OR** - Five of the following eight criteria [3]: | Criterion | Threshold | |-----------|-----------| | Fever | ≥38.5°C | | Splenomegaly | — | | Cytopenia (≥2 lineages) | Hb <9 g/dL, Platelets <100,000/µL, ANC <1,000/µL | | Hypertriglyceridemia | Fasting >265 mg/dL | | Hypofibrinogenemia | Fibrinogen <150 mg/dL | | Hemophagocytosis | In bone marrow, spleen, lymph node, or liver | | Low/absent NK cell activity | — | | Ferritin | >500 ng/mL | | Elevated soluble CD25 (sIL-2R) | — | **Key Hematologic Feature**: HLH involves **multilineage cytopenia** (at least 2 of 3 lineages) [3][6]. The bone marrow shows hemophagocytosis by activated macrophages, not isolated erythroid hypoplasia [6]. ### Pure Red Cell Aplasia (PRCA) **Definition & Pathophysiology** PRCA is a syndrome defined by normocytic normochromic anemia with severe reticulocytopenia and marked reduction or absence of erythroid precursors in the bone marrow, while granulopoiesis and megakaryocytopoiesis remain normal [5][8]. **Diagnostic Criteria** - Severe anemia with normal RBC morphology - **Low or absent reticulocyte count** - **Normal myeloid and platelet lines** - Reduced or absent erythroid precursors in normocellular marrow [7] **Key Hematologic Feature**: PRCA involves **isolated erythroid lineage suppression** with preservation of other cell lines [5][7][8]. --- ## Why HLH Cannot Present as Isolated PRCA | Feature | HLH | PRCA | |---------|-----|------| | Lineage involvement | ≥2 lineages (multilineage cytopenia) | Isolated erythroid | | Bone marrow finding | Hemophagocytosis by macrophages | Erythroid hypoplasia/aplasia | | Reticulocyte count | Variable (may be low if anemia present) | Markedly decreased or absent | | Ferritin | Markedly elevated | Normal | | Fibrinogen | Low | Normal | | Triglycerides | Elevated | Normal | | Splenomegaly | Common | Absent (unless underlying cause) | **Critical Distinction**: The diagnostic criteria for HLH explicitly require cytopenia involving **at least two of three lineages** (hemoglobin <9 g/dL, platelets <100,000/µL, ANC <1,000/µL) [3]. Isolated anemia with normal white blood cell and platelet counts—the hallmark of PRCA—would not satisfy HLH diagnostic criteria. **Potential Overlap Scenarios**: - A patient with HLH may develop **anemia as one component** of multilineage cytopenia, but this is not "isolated PRCA" - PRCA can occur in the context of **autoimmune disorders** (SLE, rheumatoid arthritis) or **lymphoproliferative disorders** (LGL leukemia, CLL) [2][7], which are also triggers for secondary HLH, but the two conditions remain distinct - **Parvovirus B19** can cause both transient aplastic crisis (PRCA-like picture) in hemolytic anemias and has been associated with HLH triggers, but again, the bone marrow findings differ --- ## Conclusion Hemophagocytic syndrome and pure red cell aplasia are mutually exclusive in their diagnostic definitions. HLH requires multilineage cytopenia with hemophagocytosis, while PRCA requires isolated erythroid aplasia with preserved other lineages. A patient presenting with isolated anemia and reticulocytopenia with normal white blood cell and platelet counts should be evaluated for PRCA and its underlying causes (thymoma, parvovirus B19, autoimmune disorders, lymphoproliferative disorders, drug-induced), not HLH. --- *This analysis is based on retrieved evidence from hematopathology textbooks and consensus guidelines. Clinical correlation with bone marrow examination, complete blood count, and appropriate serologic/molecular testing is essential for accurate diagnosis.*